High-tech imaging reveals details about rare eye disorder

Scientists have identified key corneal neurons involved in sensitivity and developed an experimental model to study nerve regeneration. The Ocular Neurobiology laboratory is participating in the RESTORE VISION project, which aims to improve eye health and quality of life for those affected by rare eye diseases.

A study published in JAMA reports on the eye's functioning after a whole-eye transplant, revealing normal pressure and blood flow over time. The transplanted eye has maintained some remaining structure in the retina, offering hope for future sight restoration.

Researchers at Mass Eye and Ear developed an mRNA-based therapy to prevent scarring and blindness in PVR. The treatment, called RUNX1-Trap, targets a protein that regulates scar tissue formation, showing early promise for treating this eye disease.

Healome Therapeutics has secured £2m in funding to develop an eye drop technology that combines drug retention, lubrication, and protection. The platform aims to reduce dosing regimens and improve patient outcomes for diseases affecting the surface of the eye, including dry eye disease and rare ocular surface conditions.

Researchers developed a new imaging technique using shortwave-infrared (SWIR) imaging to visualize the lymphatic system, improving resolution and sensitivity compared to traditional near-infrared (NIR) imaging. SWIR imaging with silver sulfide quantum dots offers superior image resolution and outperforms NIR-I imaging techniques.

Researchers developed DF-FPDT to address low-frequency loss from non-matched illumination in live-cell imaging, enabling high-resolution and high-contrast 3D reconstructions. This breakthrough technique leverages non-matched illumination to enhance structural details without additional hardware or post-processing.